We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Maternal Multiomic Changes Could Predict Onset of Labor

By LabMedica International staff writers
Posted on 18 May 2021
Currently, predictions of when labor will start are imprecise and based on gestational age and an average pregnancy length of 40 weeks, even though the onset of labor between week 37 and 42 of pregnancy is considered normal. More...
Having a better idea of when labor may arrive could help with planning and managing medical concerns like fetal lung maturation.

As pregnancy progresses toward labor, major transitions occur in fetomaternal immune, metabolic, and endocrine systems that culminate in birth. The comprehensive characterization of maternal biology that precedes labor is crucial to understanding these physiological transitions and identifying predictive biomarkers of delivery.

A large team of multidisciplinary scientists led by Stanford University School of Medicine (Palo Alto, CA, USA) followed more than 60 women toward the end of their pregnancies, collecting blood samples for metabolic, protein, and immune analysis. They collected a median of three blood samples from each participant within the 100 days preceding labor. Using untargeted mass spectrometry and an aptamer-based proteomic platform, the team tallied the levels of 3,529 metabolites and 1,317 proteins, while using a mass cytometry assay to gauge nearly 2,300 immune features over time.

The investigators pieces together a picture of the changes that occur in the two to four weeks prior to delivery. For instance, the levels of steroid hormones like progesterone and cortisol rose dramatically. At the same time, levels of factors involved in angiogenesis fell; a change they said could help weaken the connection between the uterus and the placenta, priming them for delivery.

Additional shifts affected the immune system. There was a rise in interleukin-1 receptor type 4 (IL-1R4) levels, which inhibits the inflammatory factor IL-33, suggesting that this change may tamp down inflammatory responses that might otherwise be triggered during labor. In addition, the increase in IL-1R4 levels could serve a labor-initiation signal. By feeding these changes into a model, the scientists developed a tool to predict when someone is about to go into labor. After training on their 53 cohort members, they tested their predictor on data from a further 10 women to find that it had high accuracy in predicting the time to labor. They further noted that the model could predict both preterm and term labor.

Virginia Winn, MD, an associate professor of obstetrics and gynecology and co-author of the study, said, “If we understand what's regulating labor, we might be able to do a better job of inducing labor.” The study was published on May 5, 2021 in the journal Science Translational Medicine.


Related Links:
Stanford University School of Medicine


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Automatic Hematology Analyzer
CF9600
New
Gold Member
Serum Indices Control
Acusera Serum Indices Control
Japanese Encephalitis Test
Japanese Encephalitis Virus Real Time PCR Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: NTM are about 200 environmental bacteria found in soil and water that can cause chronic, tuberculosis-like lung infections but are distinct from the Mycobacterium tuberculosis complex (Image Credit: Adobe Stock)

Rapid CRISPR Test Identifies Nontuberculous Mycobacteria Species from Respiratory Samples

Chronic lung infections caused by nontuberculous mycobacteria (NTM) are increasingly recognized but frequently mistaken for tuberculosis, complicating diagnosis and care. These infections may affect as... Read more

Immunology

view channel
Image: Although many people harbor latent Epstein-Barr virus (EBV), growing evidence has linked the virus to MS pathobiology (Image Credit: Adobe Stock)

Blood EBV Activity Biomarkers May Predict Multiple Sclerosis Relapse Months Ahead

Predicting relapse in multiple sclerosis (MS) remains difficult, limiting opportunities for timely intervention and monitoring. Although many people harbor latent Epstein-Barr virus (EBV), growing evidence... Read more

Microbiology

view channel
Image: Graphical Abstract (Jose A. Céspedes, Maria I. Montañez, Isabel M. Jiménez, et al. Magnetic nanoparticles enable clinically relevant in vitro diagnosis of beta-lactam allergy. Materials Today Bio (2026). DOI: 10.1016/j.mtbio.2026.103356)

Magnetic Nanoparticles Enable More Sensitive Beta-Lactam Allergy Testing

Penicillin allergy labels are common in clinical practice, yet many are incorrect and can lead to suboptimal antibiotic choices. Although 8%–25% of people report a penicillin allergy, only 1%–10% are truly... Read more

Pathology

view channel
Image Credit: Adobe Stock

Machine Learning Cytology Tool Improves Cancer Cell Identification

Cytological screening remains central to early cancer detection, but its accuracy depends heavily on expert interpretation of stained cells. Under conventional microscopy, malignant and reactive cells... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image: The acquisition adds Convergent Genomics’ UroAmp platform and proprietary urinary tumor DNA technology to Veracyte’s portfolio (Photo courtesy of Convergent Genomics)

Veracyte Acquisition Expands Urine-Based Bladder Cancer Monitoring Capabilities

Veracyte, Inc. has acquired Convergent Genomics, expanding its urology diagnostics offerings with the company’s UroAmp platform and proprietary urinary tumor DNA (utDNA) technology. UroAmp has been clinically... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.